B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 820 KRW 2.37% Market Closed
Market Cap: 117.9B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note
Bio-FD&C Co Ltd
/
Income Statement
/
Cost of Revenue

Bio-FD&C Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio-FD&C Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Cost of Revenue
-₩4.6B
CAGR 3-Years
-15%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cost of Revenue
-₩1.6T
CAGR 3-Years
-30%
CAGR 5-Years
-29%
CAGR 10-Years
-31%
SK Bioscience Co Ltd
KRX:302440
Cost of Revenue
-₩227.3B
CAGR 3-Years
-20%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cost of Revenue
-₩85.3B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cost of Revenue
-₩92B
CAGR 3-Years
-29%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cost of Revenue
-₩42.2B
CAGR 3-Years
-9%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
No Stocks Found

Bio-FD&C Co Ltd
Glance View

Market Cap
117.9B KRW
Industry
Biotechnology

Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. The company is headquartered in Incheon, Incheon and currently employs 61 full-time employees. The company went IPO on 2022-02-21. The firm is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The firm's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.

Intrinsic Value
15 556.25 KRW
Undervaluation 11%
Intrinsic Value
Price
B
What is Intrinsic Value?

See Also

What is Bio-FD&C Co Ltd's Cost of Revenue?
Cost of Revenue
-4.6B KRW

Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Cost of Revenue amounts to -4.6B KRW.

What is Bio-FD&C Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-9%

Over the last year, the Cost of Revenue growth was 6%. The average annual Cost of Revenue growth rates for Bio-FD&C Co Ltd have been -15% over the past three years , -9% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.